Press Releases
 
Antidiabetics Market to Incur Rapid Extension During 2015 - 2023

, 17 April 2019 -- Antidiabetics Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2015 - 2023

The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for diabetes have become the focal point of attention due to the burgeoning diabetic population size, with diabetes affecting middle age groups and children across all income groups globally.

The anti-diabetics market has been segmented based on type of drug class into biguanides (metformin), sulfonylureas (glimepiride), meglitinides (repaglinide), thiazolidinediones (pioglitazone), dipeptidyl peptidase IV (DPP-IV) inhibitors (sitagliptin), and α-glucosidase inhibitors (acarbose).

Among these drug classes, Biguanides act directly against insulin resistance. Sulfonylureas (SUs) were the earliest drug classes in the market for treatment of diabetes and have a significant market presence. α-glucosidase inhibitors delay postprandial glucose absorption by hydrolysis of disaccharide is into monosaccharide’s in the small intestine. Meglitinides are prandial insulin releasers that stimulate rapid insulin secretion. The thiazolidinediones are insulin-sensitizing drugs, which improve whole-body insulin sensitivity through gene regulation. DPP-IV inhibitors make a significant impact on glucose tolerance and make lasting improvements in the health outcomes of diabetic patients.

Some of the major drivers and opportunities for growth of this market include drug combinations of several agents such as sitagliptin and metformin and other drug combinations that are in different stages of clinical and pipeline development. Increase in the prevalence of diabetes and new product launches by major pharmaceutical companies re some of the key drivers for growth in this market. In 2015, Boehringer Ingelheim GmbH launched two new drugs (Synjardy & Glyxambi)for treatment of diabetes mellitus type II.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8809

Some of the key opportunities for the antidiabetics include a strong pipeline for antidiabetics and entry of new players in the market, for instance, Novo Nordisk’s diabetes drug’s Tresiba, and Ryzodeg received FDA approval in September 2015. Moreover, Boehringer Ingelheim GmbH has a strong pipeline for anti-diabetic drugs, such as Linagliptin which is a dipeptidyl peptidase (DPP) 4 inhibitor) for patients suffering from diabetes mellitus type II and high cardiovascular risk.

However, despite the availability of numerous branded antidiabetic drugs, many of these drugs have lost patent protection. In the wake of huge pressures from government and regulatory authorities, which have banned top selling drugs in various countries, in order to promote generic drugs at lower costs for diabetic patients. For instance, Mankind Pharma, launched anti-diabeticDynaglipt (Teneligliptin) under the drug class DPP-4 inhibitors in November 2015 in India targeting the middle to low income diabetic patient population.

As a result, the volume of antidiabetics is expected to shift to first generation drugs and other generic drugs in the market. Moreover, there is a huge unmet medical need for antidiabetics that can treat multiple chronic disorderscoexisting with diabetessuch as cardiovascular diseases, dyslipidemia, hypertension etc. Another major restraint in the antidiabetics market is reduction in the efficacy of drugs over a period and canlead to other health complications.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=8809

Some of the major players in the market include Astra Zeneca plc, Boehringer Ingelheim GmbH, Eli Lilly & Co., Johnson & Johnson, Mankind Pharma Ltd., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, SanofiS.A., and Teva Pharmaceutical Industries Ltd.

# # #


Submitted by hawer on Wednesday, 17 April 2019 at 10:02 PM
Category: Health Care & Medical
 
Related News

Healthcare Automation Market: Rising Clinical Research Activities to Bolster the Demand of the Marke
Thursday, 20 Jun 2019

Cell Expansion Market - Key Players Keen on Tapping into the Opportunities in the Emerging Economies
Thursday, 20 Jun 2019

Marine Derived Drugs Market Developments, Growth and 2016 – 2024 Forecast Research Study
Wednesday, 19 Jun 2019

Operation Theatre Lights Market Industry Demands, Top Key Players, Industry Analysis & Forecast By 2
Wednesday, 19 Jun 2019

Autoimmune Treatment Market Key Report 2014 and Future Opportunity Assessment 2024
Wednesday, 19 Jun 2019

Related Events

2nd Journal of Thermal Analysis and Calorimetry Conference
Tuesday, 18 Jun 2019

Vestibular Schwannoma Conference 2019
Wednesday, 19 Jun 2019

Biomarkers And Diagnostics for Complex And Rare Diseases
Wednesday, 19 Jun 2019

2nd International Public Mental Health Conference
Wednesday, 19 Jun 2019

III World Congress and VI International Congress on Dual Disorders ICDD2019
Wednesday, 19 Jun 2019

Latest News

Healthcare Automation Market: Rising Clinical Research Activities to Bolster the Demand of the Marke
Thursday, 20 Jun 2019

An Insight of common types of roofing systems
Thursday, 20 Jun 2019

Cell Expansion Market - Key Players Keen on Tapping into the Opportunities in the Emerging Economies
Thursday, 20 Jun 2019

Sex Dating Online - The Way to Hook With Ladies of All Ages
Wednesday, 19 Jun 2019

3 Strategies For Buying Edibles Online
Wednesday, 19 Jun 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Thursday, 20 June 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • ESPNIC 2019
  • Palo Alto Networks: Security Simplified - Enterprise Security Series
  • 2nd Journal of Thermal Analysis and Calorimetry Conference
  • EPHJ-EPMT-SMT Trade Show
  • Palo Alto Networks: May - Palo Alto Networks Heads-up

  • Latest Jobs
    Sorry, there are currently no entries posted here.